{"id":649843,"date":"2023-05-01T15:44:01","date_gmt":"2023-05-01T15:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=649843"},"modified":"2023-05-01T15:44:01","modified_gmt":"2023-05-01T15:44:01","slug":"ulcerative-colitis-market-analysis-market-size-epidemiology-leading-companies-working-in-the-market-companies-eli-lilly-and-company-janssen-galapagos-gilead-theravance-biopharma-arena","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/ulcerative-colitis-market-analysis-market-size-epidemiology-leading-companies-working-in-the-market-companies-eli-lilly-and-company-janssen-galapagos-gilead-theravance-biopharma-arena_649843.html","title":{"rendered":"Ulcerative Colitis Market Analysis, Market Size, Epidemiology, Leading Companies Working in the Market | Companies – Eli Lilly and Company, Janssen, Galapagos, Gilead, Theravance Biopharma, Arena"},"content":{"rendered":"
\n
\"Ulcerative<\/a><\/div>\n
\n
Ulcerative Colitis Market<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Ulcerative Colitis (UC) – Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Ulcerative Colitis (UC), historical and forecasted epidemiology as well as the Ulcerative Colitis (UC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n

DelveInsight has launched a new report on “Ulcerative Colitis – Market Insights, Epidemiology, and Market Forecast-2032”.<\/strong><\/p>\n

DelveInsight’s “Ulcerative Colitis – Market Insights, Epidemiology, and Market Forecast-2032<\/a><\/strong>″ report delivers an in-depth understanding of the Ulcerative Colitis, historical and forecasted epidemiology as well as the  Ulcerative Colitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

Some of the key facts of the Report:<\/strong><\/p>\n

    \n
  1. The total prevalent population of Ulcerative Colitis in the 7MM in 2020 was 2,201,831. These cases are expected to rise by 2032, during the forecast period [2022–2032]. <\/li>\n
  2. According to DelveInsight’s analysis, in the 7MM, the United States reported the highest prevalent cases of Ulcerative Colitis, i.e., 1,008,823 which accounted for nearly 46% of the total 7MM cases, in the year 2020. <\/li>\n
  3. Among the EU-5 countries, the highest number of cases of Ulcerative Colitis was in Germany, i.e., 342,785 cases in the year 2020. <\/li>\n<\/ol>\n

    Key benefits of the report:<\/strong><\/p>\n

      \n
    1. Ulcerative Colitis market report covers a descriptive overview and comprehensive insight of the Ulcerative Colitis epidemiology and Ulcerative Colitis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)<\/li>\n
    2. The Ulcerative Colitis market report provides insights on the current and emerging therapies.<\/li>\n
    3. Ulcerative Colitis market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n
    4. The Ulcerative Colitis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Ulcerative Colitis market.<\/li>\n<\/ol>\n

      Got queries? Click here to know more about Ulcerative Colitis Market Landscape<\/a>.<\/strong><\/p>\n

      Ulcerative Colitis Overview<\/strong><\/p>\n

      Ulcerative colitis is usually only in the innermost lining of the large intestine (colon) and rectum. Forms range from mild to severe. Having ulcerative colitis puts a patient at increased risk of developing colon cancer.<\/p>\n

      The key players involved in the Ulcerative Colitis market<\/a>:<\/strong><\/p>\n